Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - SKYSTAR BIO-PHARMACEUTICAL CO | Financial_Report.xls |
| EX-32.1 - EXHIBIT 32.1 - SKYSTAR BIO-PHARMACEUTICAL CO | v386572_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - SKYSTAR BIO-PHARMACEUTICAL CO | v386572_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - SKYSTAR BIO-PHARMACEUTICAL CO | v386572_ex31-2.htm |
| 10-Q - 10-Q - SKYSTAR BIO-PHARMACEUTICAL CO | v386572_10q.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Skystar Bio-Pharmaceutical Company, (the “Company”) on Form 10-Q for the quarter ended June 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bing Mei, Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:
(1) The Report fully complies with the requirements of section 13 (a) or 15 (d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated.
| /s/ Bing Mei | |
| August 14, 2014 | Bing Mei |
| Chief Financial Officer |
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.